Calamos Advisors’s enGene Therapeutics Warrants ENGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
2025
Q4
$418K Sell
2025
Q3
$108K Hold
2025
Q2
$118K Hold
2025
Q1
$96K Hold
2024
Q4
$128K Hold
2024
Q3
$214K Hold
2024
Q2
$209K Hold
2024
Q1
$780K Sell
2023
Q4
$213K Buy